Table 2 Genetic associations with EGPA
Total EGPA N = 534 | MPO+ EGPA N = 159 | ANCA −ve EGPA N = 352 | cFDR asthma analysis N = 10,365 | cFDR EC analysis N = 175,000 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chr | Variant rsid | Gene/ Region | Cont maf | Case maf | OR | LMM P | Meta OR | Meta P | MPO OR | MPO P | OR | P | P asthma | cFDR^ (EGPA| asthma) | P EC | cFDR‡ (EGPA| EC) |
2 | rs72946301 | BCL2L11 | 0.1 | 0.17 | 1.66 | 1.9 × 10−10 | 1.81 | 9.0 × 10−11 | 1.89 | 7.7 × 10−5 | 1.76 | 3.6 × 10−7 | ||||
5 | rs1837253 | TSLP | 0.26 | 0.17 | 1.42 | 1.5 × 10−10 | 1.52 | 5.2 × 10−11 | 1.46 | 0.0008 | 1.53 | 1.2 × 10−8 | ||||
6 | rs9274704 | HLA-DQ | 0.17 | 0.27 | 1.98 | 8.2 × 10−16 | 2.01 | 1.2 × 10−20 | 5.68 | 1.1 × 10−28 | 1.32 | 0.004 | ||||
10 | rs34574566 | 10p14 | 0.31 | 0.24 | 0.73 | 8.0 × 10−8 | 0.7 | 2.9 × 10−8 | 0.66 | 0.0004 | 0.7 | 9.9 × 10−6 | ||||
7 | rs42041 | CDK6 | 0.24 | 0.31 | 1.32 | 1.9 × 10−6 | 1.34 | 0.014 | 1.36 | 9.7 × 10−5 | 4.5 × 10−8 | 0.0003 | ||||
5 | rs11745587† | IRF1/IL5 | 0.35 | 0.4 | 1.31 | 2.1 × 10−7 | 1.16 | 0.17 | 1.47 | 1.8 × 10−8 | 0.002 | 1.9 × 10−5 | 1.6 × 10−29 | 3.6 × 10−5 | ||
6 | rs6454802 | BACH2 | 0.4 | 0.31 | 0.8 | 2.2 × 10−6 | 0.81 | 0.024 | 0.74 | 3.8 × 10−6 | 0.002 | 0.0002 | 1.0 × 10−18 | 0.0002 | ||
3 | rs9290877 | LPP | 0.3 | 0.38 | 1.27 | 4.7 × 10−6 | 1.48 | 0.0007 | 1.24 | 0.0006 | 9.0 × 10−14 | 0.0002 | ||||
1 | rs72689399 | GPA33 | 0.01 | 0.03 | 2.7 | 6.7 × 10−7 | 0.89 | 0.96 | 5.34 | 1.1 × 10−9 | ||||||
6 | rs6931740 | HLA | 0.39 | 0.25 | 0.62 | 1.7 × 10−10 | 0.55 | 1.6 × 10−5 | 0.61 | 4.2 × 10−8 | ||||||
12 | rs78478398 | 12q21 | 0.03 | 0.05 | 0.59 | 0.0017 | 0.17 | 1.7 × 10−8 | 0.81 | 0.37 | ||||||